DOUG Douglas Elliman Inc. Insider Trading

Director Bartels purchases 135,000 shares across 3 transactions at avg $1.88; holdings surge 228.9% to 194.0K shares.

Patrick J Bartels Jr, a Douglas Elliman Director, executed 3 separate purchases totaling 135,000 shares for $253,682.43 between May 8–12, 2025, at prices between $1.84 and $1.92. This transaction increased his total holdings from 58,975 to 193,975 shares, representing a 228.9% increase in his position size. The blended average purchase price of $1.88 sits just 0.5% below the current market price of $1.89, while the stock has recovered 23.5% over 30 days and is currently 30.0% below its 52-week high of $2.70. The company remains unprofitable (latest full fiscal year net income was negative) despite posting 4.2% annual revenue growth and $253.4M in the most recent quarterly revenue. This significant accumulation by a director warrants investor attention given the scale of the position increase and the company's current profitability challenge.

Howard M Lorber sells 1,081,414 DOUG shares at $1.68 (44.3% of position) as stock trades near 52-week low vs high of $3.10

Lorber executed a substantial reduction of his Douglas Elliman stake, selling 1,081,414 shares at $1.68 and retaining 1,358,499 shares post-transaction. The sale occurred at a price 44.3% below the 52-week high of $3.10 and represents a 55.7% discount to the current price of $2.39. His prior three trades at this ticker (July 2024) were well-timed with 90-day gains of 51.8%, 60.4%, and 71.6%, suggesting effective pattern recognition; the current sale at depressed levels may reflect similar timing judgment relative to fundamentals. Douglas Elliman faced headwinds with annual revenue declining 17.1% year-over-year and posted a $-27.2M net loss in the latest quarter, underpinning the stock's compression toward 52-week lows despite recent 30-day volatility of +64.8%.

Michael Liebowitz buys 1,081,414 shares of DOUG at $1.68; holdings now 1,478,382 shares (+272.4%). Current price $2.27, +46.4% in 30 days.

Liebowitz purchased 1,081,414 shares of Douglas Elliman at $1.68 on 2024-11-18, tripling his stake to 1,478,382 shares post-transaction. His prior trades at DOUG show mixed timing: a July 2024 buy returned +57.6% in 30 days and +33.0% in 90 days, while an August 2023 buy gained +7.8% at 30 days but fell -17.4% at 90 days. The company's fundamentals remain challenged, with annual revenue declining -17.1% and full-year net income negative at $-27,180,000.00. Stock has risen +46.4% over the past 30 days from this purchase level, currently trading at $2.27, though it remains -26.8% below its 52-week high, suggesting recovery from a depressed state rather than continued momentum.

Director Mark Zeitchick bought 40,000 shares of DOUG at $1.18; stock down 59.7% from 52-week high amid company unprofitability

Mark Zeitchick, a director at Douglas Elliman Inc., purchased 40,000 shares at $1.18 on 2024-07-10, bringing his holdings to 297,310 shares—a 15.5% increase. The transaction occurred as the stock trades at $1.25, down 59.7% from its 52-week high of $3.10, and follows consecutive insider buys on 2024-07-08 and 2024-07-09. Douglas Elliman reported a latest quarterly revenue of $200.2M but a net loss of $-41.5M, with annual revenue declining 17.1% year-over-year; the company remains unprofitable on a full-year basis and carries a market cap of $114.3M. The filing also reflects a broader cluster, as 3 other insiders purchased shares within the same 14-day window. Notably, across Zeitchick's cross-ticker track record of 2 prior buys, timing outcomes are not yet measurable; his same-ticker history at DOUG shows two recent purchases with outcomes similarly not yet determinable, so no track record exists to evaluate execution quality at this ticker or broader pattern success.

COO Richard Lampen buys 75,000 DOUG shares at $1.20; part of cluster activity as stock trades -60.6% from 52-week high.

Richard Lampen, Executive Vice President & COO, purchased 75,000 shares at $1.20, bringing his holdings to 2,272,804 shares, in a transaction filed within days of two other insider buys at Douglas Elliman. The cluster activity is notable given Douglas Elliman's stressed fundamentals: the company posted -$41,475,000 net income on $200,239,000 quarterly revenue with -17.1% annual revenue decline and currently trades -60.6% from its 52-week high of $3.10. Lampen's own prior trades at DOUG show mixed timing: two of his three measurable buys at this ticker were followed by 90-day gains (60.5% and 47.4% respectively), though his cross-ticker track record shows a 75.00% win rate on buys with an average 90-day return of +5.0%. At current price of $1.22, the stock has already retraced -0.2% since this purchase, and the company remains unprofitable.

Director Liebowitz Michael bought 197,398 shares of DOUG at $1.18, nearly doubling holdings; company unprofitable with -17.1% annual revenue decline.

Director Michael Liebowitz purchased 197,398 shares at $1.18 on 2024-07-10, increasing his holdings from 199,570 shares to 396,968 shares—a 98.9% increase. The purchase occurs within a cluster of 3 other insider buys in the past 14 days. However, several headwinds limit the significance: Douglas Elliman reported -$41.5M net income on $200.2M revenue in the latest quarter and experienced -17.1% annual revenue growth, indicating sustained unprofitability. At $1.22 current price, the stock trades -60.6% from its 52-week high of $3.10, and Liebowitz's prior buy at this ticker (August 2023 at an earlier price) posted a negative 90-day return of -17.4%. His cross-ticker track record shows only a 25% win rate at the 90-day mark despite modest 30-day strength. The transaction signals activity by multiple board members during a period of sharp valuation compression, but the company's deteriorating fundamentals and the director's mixed historical timing limit confidence in this as a strong conviction signal.

Director ZEITCHICK MARK bought 112,750 shares in 2 transactions for $127,127.91; cluster buy pattern with 3 other insiders in past 14 days

ZEITCHICK MARK executed 2 separate purchases totaling 112,750 shares (112.8K shares) for $127,127.91 at blended average price $1.13 on July 8-9, 2024, increasing holdings by 78.0% from 144,560 to 257,310 shares. The purchases occur as the stock trades at $1.23, down 60.3% from its 52-week high of $3.10, while the company faces headwinds: annual revenue declined 17.1%, the firm posted negative net income of $-41,475,000.00 ($-41.5M) last quarter, and full-year profitability remains negative. A cluster pattern is present—3 other insiders also bought within the past 14 days—suggesting coordinated director-level activity during a period of operational and valuation pressure.

CEO Lorber bought 100,000 shares at blended avg $1.15 across 3 transactions; stock down -60.3% from 52-week high amid unprofitability.

Lorber purchased 100,000 shares (100.0K shares) for $114,562.93 across three separate buys on July 8–10, 2024, at transaction prices ranging from $1.09 to $1.22 (blended average $1.15). The stock currently trades at $1.23, having fallen -60.3% from its 52-week high of $3.10, while the company reported a net loss of $-41,475,000.00 over its most recent fiscal year and annual revenue declined -17.1%. Notably, a cluster of 3 other insiders also purchased shares within the past 14 days, indicating coordinated board or management activity in the same period. Lorber's prior buy at this ticker (2023-08-21) showed a negative 90-day return (-20.0%), and his cross-ticker track record shows a 0% win rate on prior buys over the 90-day horizon, suggesting his historical transaction timing has not been favorable.

EVP/COO Richard Lampen bought 155,000 shares across 2 transactions (avg $1.09) while company posts -17.1% revenue decline and $-41.5M net loss.

Richard Lampen, Executive Vice President & COO, completed 2 separate purchases totaling 155,000 shares for $169,460.50 between July 5 and July 9, 2024, at an average blended price of $1.09 per share. His holdings increased from 2,042,804 to 2,197,804 shares (+7.6%). This acquisition occurs against a backdrop of material operational strain: the company reported latest-quarter revenue of $200,239,000.00 with net income of $-41,475,000.00, and annual revenue has contracted -17.1% year-over-year. Additionally, 2 other insiders bought within the past 14 days, forming a cluster buying pattern. The stock trades 62.3% below its 52-week high of $3.10, though it has recovered +6.4% over the past 30 days. At this company-specific ticker, Lampen's 3 prior purchases showed mixed timing outcomes: 2 of 3 were well-timed at the 90-day mark, with returns ranging from -17.8% to +60.5% across those intervals.